Publication | Closed Access

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: The effects of PEGylation degree and drug conjugation style

Drug Conjugation StyleMedicinal ChemistryDrug TargetingTumor-selective TargetingMedicinePolymer-drug ConjugatePolyamidoamine DendrimerPharmacotherapyAnti-cancer AgentTumor TargetingDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery